Skip to main content
Livermore
Livermore
ZHEN

STRS Ohio

SEC CIK
0000820478
Latest filing
Jul 30, 2026

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by STRS Ohio, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings

Shares (Q2 2026)
33,364
Value
$10.0M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of ALNY by STRS Ohio, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202633,364$10.0M<0.1%−2,168−6.1%ReducedHolders
Q1 202635,532$11.8M<0.1%+7,496+26.7%AddedHolders
Q4 202528,036$11.1M<0.1%+51+0.2%AddedHolders
Q3 202527,985$12.8M<0.1%−2,155−7.1%ReducedHolders
Q2 202530,140$9.83M<0.1%+1,323+4.6%AddedHolders
Q1 202528,817$7.78M<0.1%+3,817+15.3%AddedHolders
Q4 202425,000$5.88M<0.1%−4,468−15.2%ReducedHolders
Q3 202429,468$8.10M<0.1%+4,468+17.9%AddedHolders
Q2 202425,000$6.08M<0.1%00.0%UnchangedHolders
Q1 202425,000$3.74M<0.1%00.0%UnchangedHolders
Q4 202325,000$4.79M<0.1%00.0%UnchangedHolders
Q3 202325,000$4.43M<0.1%−5,000−16.7%ReducedHolders
Q2 202330,000$5.70M<0.1%+25,472+562.5%AddedHolders
Q1 20234,528$907.0K<0.1%+905+25.0%AddedHolders
Q4 20223,623$861.0K<0.1%+312+9.4%AddedHolders
Q3 20223,311$662.0K<0.1%+3,311NewHolders
Q2 20220$00.0%−5,291−100.0%Sold outHolders
Q1 20225,291$863.0K<0.1%+4,000+309.8%AddedHolders
Q4 20211,291$218.0K<0.1%00.0%UnchangedHolders
Q3 20211,291$243.0K<0.1%00.0%UnchangedHolders
Q2 20211,291$218.0K<0.1%−3,029−70.1%ReducedHolders
Q1 20214,320$609.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.